Brief: Alphamab Oncology Says Unit And Sunshine Lake Pharma Co Entered Into Collaboration Agreement
28/05/2020 16:33
May 28 (Reuters) - Alphamab Oncology 9966.HK :
* UNIT AND SUNSHINE LAKE PHARMA CO ENTERED INTO
COLLABORATION
AGREEMENT TO JOINTLY DEVELOP AN ANTI-TUMOR COMBINATION THERAPY
Source text for Eikon: ID:nHKS2qwhvB
Further company coverage: 9966.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)